Children’s Hospital Los Angeles Names Neurologist Jonathan Santoro as Neurological Institute Co-Director
Event summary
- Jonathan D. Santoro, MD, appointed Chief of Neurology and Co-Director of the Neurological Institute at Children’s Hospital Los Angeles (CHLA) on February 12, 2026.
- Santoro previously served as Interim Chief and Director of Neuroimmunology at CHLA.
- CHLA’s Neurological Institute is ranked No. 10 in the nation by U.S. News & World Report for 2025–26.
- Santoro leads NIH-funded research on Down syndrome regression disorder and has authored over 100 peer-reviewed publications.
- He will co-direct the institute with Mark D. Krieger, MD, Surgeon-in-Chief at CHLA.
The big picture
The appointment of Jonathan Santoro as Co-Director of the Neurological Institute at CHLA underscores the hospital’s commitment to strengthening its pediatric neurology and neurosurgery programs. Santoro’s expertise in neuroimmunology and his track record of NIH-funded research align with CHLA’s goal of advancing care for complex neurological conditions. This leadership change comes as CHLA maintains its top 10 ranking in pediatric neurology, reflecting its ongoing investment in high-impact research and clinical innovation.
What we're watching
- Research Impact
- How Santoro’s NIH-funded research on Down syndrome regression disorder will influence clinical trials and treatment protocols at CHLA.
- Institutional Growth
- Whether Santoro’s leadership can further elevate CHLA’s Neurological Institute rankings and research funding.
- Strategic Expansion
- The pace at which Santoro will advance clinical trials and translational research under his new role.
Related topics